¿Àµµ¿¬
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : Ç÷¾×, Ç÷ÀüÁöÇ÷
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
186
ÇØ¿Ü
Raskob GE, van Es N, Seger A, Angchaisuksiri P, Oh D, Boda Z, Lyons R,. Meijer K,. Gudz I, Weitz JI, Zhang G, Lanz H, Mercur MF, Büller HR. Edoxaban for venous thromboembolism in cancer patients: subgroup results from the Hokusai-VTE randomized trial. Lancet Haematol 2016 Aug;3(8):e379-87.
185
±¹³»
Cho HJ, Chong SY, Kim JO, Huh JY, Kim NK, Park Y, Kim MG, Oh D. A case of atypical hemolytic uremic syndrome associated with c.1273C>T mutation in the complement C3 gene. Blood Res 2016 Sep;51(3):210-213
184
ÇØ¿Ü
Brekelmans MP, Bleker SM, Bauersachs R, Boda Z, Büller HR, Choi Y, Gallus A, Grosso MA, Middeldorp S, Oh D, Raskob G, Schwocho L, Cohen AT. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. 2016 Thromb Haemost Jul 4;116(1):155-61
183
ÇØ¿Ü
Nakamura M, Wang YQ, Wang C, Oh D, Yin WH, Kimura T, Miyazaki K, Abe K, Mercuri M, Lee LH, Segers A, Büller H. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial. J Thromb Haemost. 2015 Sep;13(9):1606-14.
182
ÇØ¿Ü
Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, Grandone E, Pasca S, Di Minno MN, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Oh D, D"Amico E, Becattini C, De Stefano V, Vidili G, Vaccarino A, Nardo B, Di Nisio M, Dentali F. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015 Sep 1;175(9):1474-80.
181
ÇØ¿Ü
Cho SH, Ko JJ, Kim JO, Jeon YJ, Yoo JK, Oh J, Oh D, Kim JW, Kim NK. Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population. PLoS One. 2015 Jul 6;10(7):e01311253"-UTR
180
ÇØ¿Ü
Kim JW, Jeon YJ, Jang MJ, Kim JO, Chong SY, Ko KH, Hwang SG, Oh D, Oh J, Kim NK. Association between folate metabolism-related polymorphisms and colorectal cancer risk. Mol Clin Oncol. 2015 May;3(3):639-648.
179
ÇØ¿Ü
Kim HY, Lee KO, Yoo KH, Kim SH, Oh D, Kim HJ. Congenital thombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) caused by novel ADAMTS13 mutations. Br J Haematol. 2015 Jun 18. doi: 10.1111/bjh.13564
178
ÇØ¿Ü
Joo Jeon Y, Woo Kim J, Mi Park H, Kim JO, Geun Jang H, Oh J, Gyu Hwang S, Won Kwon S, Oh D, Keun Kim N. Genetic variants in 3"-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans. Sci Rep. 2015 Jun 5;5:11006. doi: 10.1038/srep11006.
177
ÇØ¿Ü
Yhim HY, Jang MJ, Bang SM, Kim KH, Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW, Oh D. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2014 Jul;12(7):1035-43.
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729